Roth Capital Forecasts OTCMKTS:GTBIF Q4 Earnings

Green Thumb Industries Inc. (OTCMKTS:GTBIFFree Report) – Equities researchers at Roth Capital issued their Q4 2024 earnings per share estimates for shares of Green Thumb Industries in a research note issued on Sunday, November 10th. Roth Capital analyst W. Kirk expects that the company will earn $0.07 per share for the quarter. Roth Capital has a “Strong-Buy” rating on the stock. The consensus estimate for Green Thumb Industries’ current full-year earnings is $0.32 per share. Roth Capital also issued estimates for Green Thumb Industries’ FY2024 earnings at $0.32 EPS, Q1 2025 earnings at $0.07 EPS, Q2 2025 earnings at $0.08 EPS, Q3 2025 earnings at $0.07 EPS, Q4 2025 earnings at $0.08 EPS and FY2025 earnings at $0.30 EPS.

GTBIF has been the subject of several other reports. Ventum Cap Mkts upgraded Green Thumb Industries to a “strong-buy” rating in a research note on Tuesday, August 6th. Craig Hallum upgraded Green Thumb Industries to a “strong-buy” rating in a research report on Monday, September 16th. Three analysts have rated the stock with a buy rating and three have issued a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Strong Buy” and an average target price of $16.50.

Read Our Latest Analysis on GTBIF

Green Thumb Industries Stock Down 4.2 %

Shares of OTCMKTS:GTBIF opened at $9.29 on Wednesday. Green Thumb Industries has a 12-month low of $7.50 and a 12-month high of $16.33. The company’s 50 day moving average price is $10.23 and its two-hundred day moving average price is $11.05. The firm has a market cap of $1.97 billion, a PE ratio of 34.41 and a beta of 1.40.

Green Thumb Industries (OTCMKTS:GTBIFGet Free Report) last released its quarterly earnings results on Thursday, November 7th. The company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.02). Green Thumb Industries had a net margin of 5.38% and a return on equity of 3.39%. The business had revenue of $286.87 million during the quarter, compared to analyst estimates of $283.96 million.

About Green Thumb Industries

(Get Free Report)

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.

See Also

Earnings History and Estimates for Green Thumb Industries (OTCMKTS:GTBIF)

Receive News & Ratings for Green Thumb Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Green Thumb Industries and related companies with MarketBeat.com's FREE daily email newsletter.